Impact of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on COVID-19 in a western population. CARDIOVID registry

MLA

Pablo José Antúnez-Muiños, et al. “Impact of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers on COVID-19 in a Western Population. CARDIOVID Registry.” Revista Española de Cardiología (English Edition), vol. 74, Feb. 2021, pp. 175–82. EBSCOhost, https://doi.org/10.1016/j.rec.2020.05.018.

APA

Pablo José Antúnez-Muiños, Xoan Sanmartín-Pena, Antonio Pose-Reino, Manuel Portela-Romero, Óscar Otero-García, José Ramón González-Juanatey, Alfonso Varela-Román, Marta Pérez-Poza, Javier López-Pais, Noelia Bouzas-Cruz, Diego López-Otero, María Bastos-Fernández, Teba González-Ferrero, Carla Cacho-Antonio, Luis Valdés-Cuadrado, & Brais Díaz-Fernández. (2021). Impact of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on COVID-19 in a western population. CARDIOVID registry. Revista Española de Cardiología (English Edition), 74, 175–182. https://doi.org/10.1016/j.rec.2020.05.018

Chicago

Pablo José Antúnez-Muiños, Xoan Sanmartín-Pena, Antonio Pose-Reino, Manuel Portela-Romero, Óscar Otero-García, José Ramón González-Juanatey, Alfonso Varela-Román, et al. 2021. “Impact of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers on COVID-19 in a Western Population. CARDIOVID Registry.” Revista Española de Cardiología (English Edition) 74 (February): 175–82. doi:10.1016/j.rec.2020.05.018.